Lu JS - Search Results

1

Development and trends of surgical modalities for breast cancer in China: a review of 16-year data.

Yu KD, Di GH, Wu J, Lu JS, Shen KW, Shen ZZ, Shao ZM. Yu KD, et al. Among authors: lu js. Ann Surg Oncol. 2007 Sep;14(9):2502-9. doi: 10.1245/s10434-007-9436-2. Epub 2007 Jun 13. Ann Surg Oncol. 2007. PMID: 17564750

2

ERbeta exerts multiple stimulative effects on human breast carcinoma cells.

Hou YF, Yuan ST, Li HC, Wu J, Lu JS, Liu G, Lu LJ, Shen ZZ, Ding J, Shao ZM. Hou YF, et al. Among authors: lu lj, lu js. Oncogene. 2004 Jul 29;23(34):5799-806. doi: 10.1038/sj.onc.1207765. Oncogene. 2004. PMID: 15208676

3

Prognostic value of matrix metalloproteinases (MMP-2 and MMP-9) in patients with lymph node-negative breast carcinoma.

Li HC, Cao DC, Liu Y, Hou YF, Wu J, Lu JS, Di GH, Liu G, Li FM, Ou ZL, Jie C, Shen ZZ, Shao ZM. Li HC, et al. Among authors: lu js. Breast Cancer Res Treat. 2004 Nov;88(1):75-85. doi: 10.1007/s10549-004-1200-8. Breast Cancer Res Treat. 2004. PMID: 15538048

4

[Analysis of BRCA1 mutations in Chinese patients with early onset breast cancer and affected relatives].

Hu Z, Wu J, Lu JS, Luo JM, Han QX, Shen ZZ, Shao ZM. Hu Z, et al. Among authors: lu js. Zhonghua Zhong Liu Za Zhi. 2004 Nov;26(11):657-9. Zhonghua Zhong Liu Za Zhi. 2004. PMID: 15777502 Chinese.

5

[In vitro study of the effects of estrogen receptor beta expression on the biological behavior of a human breast cancer cell line].

Hou YF, Yuan ST, Li HC, Wu J, Lu JS, Lu LJ, Liu G, Shen ZZ, Ding J, Shao ZM. Hou YF, et al. Among authors: lu lj, lu js. Zhonghua Zhong Liu Za Zhi. 2005 Jul;27(7):389-92. Zhonghua Zhong Liu Za Zhi. 2005. PMID: 16188119 Chinese.

6

Identification of breast cancer metastasis-associated proteins in an isogenic tumor metastasis model using two-dimensional gel electrophoresis and liquid chromatography-ion trap-mass spectrometry.

Li DQ, Wang L, Fei F, Hou YF, Luo JM; Wei-Chen; Zeng R, Wu J, Lu JS, Di GH, Ou ZL, Xia QC, Shen ZZ, Shao ZM. Li DQ, et al. Among authors: lu js. Proteomics. 2006 Jun;6(11):3352-68. doi: 10.1002/pmic.200500617. Proteomics. 2006. PMID: 16637015

7

[Biological significance of E-cadherin in an inflammatory breast carcinoma cell line].

Dong HM, Liu G, Wu J, Lu JS, Luo JM, Shen ZZ, Shao ZM. Dong HM, et al. Among authors: lu js. Zhonghua Zhong Liu Za Zhi. 2006 Jan;28(1):4-7. Zhonghua Zhong Liu Za Zhi. 2006. PMID: 16737610 Chinese.

8

[A study of the combination of vinorelbine and epirubicin as neoadjuvant chemotherapy regimen in the treatment of locally advanced breast cancer].

Chen CM, Shen KW, Liu GY, Wu J, Lu JS, Zhuang CJ, Han QX, Liu BL, Shao ZM, Shen ZZ. Chen CM, et al. Among authors: lu js. Zhonghua Wai Ke Za Zhi. 2006 Jun 1;44(11):745-7. Zhonghua Wai Ke Za Zhi. 2006. PMID: 16836921 Chinese.

9

Dominant-negative E-cadherin inhibits the invasiveness of inflammatory breast cancer cells in vitro.

Dong HM, Liu G, Hou YF, Wu J, Lu JS, Luo JM, Shen ZZ, Shao ZM. Dong HM, et al. Among authors: lu js. J Cancer Res Clin Oncol. 2007 Feb;133(2):83-92. doi: 10.1007/s00432-006-0140-6. Epub 2006 Aug 24. J Cancer Res Clin Oncol. 2007. PMID: 16932944

10

Gene expression profile analysis of an isogenic tumour metastasis model reveals a functional role for oncogene AF1Q in breast cancer metastasis.

Li DQ, Hou YF, Wu J, Chen Y, Lu JS, Di GH, Ou ZL, Shen ZZ, Ding J, Shao ZM. Li DQ, et al. Among authors: lu js. Eur J Cancer. 2006 Dec;42(18):3274-86. doi: 10.1016/j.ejca.2006.07.008. Epub 2006 Sep 18. Eur J Cancer. 2006. PMID: 16979889

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

277 results

Search Page

Filters